Binance listing pushes NIGHT toward wider use, with fresh trading access and an upcoming airdrop. Rising exchange support suggests stronger interest in privacy-focused blockchain tools. Binance has officially added support for the NIGHT token, a development that extends the utility of Midnight network. The exchange listing opens access to a wider user base, offering more [...]]]>Binance listing pushes NIGHT toward wider use, with fresh trading access and an upcoming airdrop. Rising exchange support suggests stronger interest in privacy-focused blockchain tools. Binance has officially added support for the NIGHT token, a development that extends the utility of Midnight network. The exchange listing opens access to a wider user base, offering more [...]]]>

Binance Partnership Helps Drive Rational Privacy Adoption With NIGHT Support

  • Binance listing pushes NIGHT toward wider use, with fresh trading access and an upcoming airdrop.
  • Rising exchange support suggests stronger interest in privacy-focused blockchain tools.

Binance has officially added support for the NIGHT token, a development that extends the utility of Midnight network. The exchange listing opens access to a wider user base, offering more traders and developers the opportunity to interact with its privacy-based features.

Midnight stated that Binance’s involvement is expected to push NIGHT’s adoption by enabling engagement at scale. The group said,

According to Binance Wallet, trading for NIGHT will begin on Binance Alpha starting December 9. An airdrop event has also been scheduled, where eligible users can claim NIGHT using Alpha Points after trading becomes available.

Binance Joins Bybit and HTX in Listing NIGHT

NIGHT has already been listed on multiple exchanges including Bybit, Bitpanda, and HTX. This rise in listings shows that demand is increasing for blockchain solutions that offer privacy-by-design. The Midnight network uses zero knowledge proof infrastructure, which supports private decentralized applications.

Following the listing news, BNB token saw a price surge. It climbed by 2.11%, reaching $908 with a 24-hour low of $872.89 and a high of $910. Trading volume also escalated with a sharp increase of 43.18%, amounting to $1.97 billion.

At the same time, futures data revealed rising activity. According to data from CoinGlass, total open interest for BNB futures rose by 2.14% in the last 24 hours to $1.42 billion, indicating a strong level of market sentiment.

Midnight Pushes Rational Privacy into Web3

Midnight is presenting itself alongside other private blockchains like Monero and Zcash, but its approach is different. It uses a rational form of privacy that tries to balance user confidentiality with regulatory requirements.

Midnight believes that integration with Binance enhances its standing by giving the NIGHT token visibility across a massive trading base. They added,

Additionally, earlier developments also pointed to structural shifts within Binance. In the previous article we reported that the company announced changes following its full regulatory approval by the Financial Services Regulatory Authority (FSRA) at Abu Dhabi Global Market.

Starting January 2026, the platform plans to conduct its operations through three new entities: Nest Exchange Services Limited, Nest Clearing and Custody Limited, and Nest Trading Limited.

The license followed a $2 billion investment from Abu Dhabi-based MGX in March. MGX took a minority stake in Binance through the deal, showing the region’s growing interest in cryptocurrency infrastructure.

]]>
Market Opportunity
Midnight Logo
Midnight Price(NIGHT)
$0.04999
$0.04999$0.04999
-1.20%
USD
Midnight (NIGHT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26